Skip to main content

Senior scientist and Lab Head in downstream processing/protein purification (m/f/d)

Are you ready for your next challenge?
Our vision is to create novel and highly differentiated medicines. To this end, we discover and develop novel therapeutic antibodies and next generation biologics, such as bispecific antibodies, fusion proteins and new modalities. Our ambition is to deliver such novel molecules to patients with game changing clinical benefit.
We are looking for a new senior science and people leader (m/f/d) with experience in the fields of drug discovery and development who will lead a team in downstream processing. The team of highly skilled people is dedicated to the technical development of next generation antibody therapeutics and other modalities by cutting-edge technologies. In particular, the team develops innovative protein purification processes in the field of industrial bioprocessing. The department belongs to a unit called Large Molecule Research within Roche Pharma Research and Early Development (pRED). This position therefore offers the opportunity to interact with numerous functions within Roche in a global environment to deliver novel medicines to patients.
Your team in a nutshell:
You will be leading a team of 8-10 experienced associates in a highly dynamic and cross-functional environment.
The job in a nutshell:
Your work will focus on team leadership in a matrix-orientated organization. You have a strong background in bioprocessing (upstream and downstream processing of biotherapeutics). Your team is developing industrial protein purification processes to deliver novel medicines to patients.
The main tasks of this position:
  • You lead a team of highly skilled associates with a strong focus on people development
  • You feel responsible for the cross-functional workflow optimization of our labs: strong focus on people management, lab workflows and data management
  • You are responsible for the development of protein purification processes that can be applied in industrial bioprocessing
  • You advance the field by driving the identification, evaluation and implementation of highly innovative, novel technologies
  • You represent your team in global cross-departmental teams that drive portfolio projects.
  • You closely collaborate with all our global partner functions of discovery, protein analytics pharmaceutical science and pharma technical development
  • You can lead portfolio projects as a project lead and enable project decisions along the different stages and departments.
  • You are responsible for work safety
This is very important for us:
Leadership skills: you have a talent to inspire and develop people, excellent communication skills and the willingness to make and drive decisions
Team player spirit: you are passionate about building strong teams. In your teams, everyone shares the success while setbacks are viewed as an opportunity to learn
Curiosity and drive: you are willing to suggest and try new ideas by your own initiative. You take ownership and are able to engage people to work on something new.
Strategic thinking: you see the big picture, take changes as an opportunity to grow, understand the processes end-to-end and are able to take care of diverse interfaces.
Presentation skills: you are used to present yourself and your work in a clear and convincing way in front of big audiences and management boards.
And the technical requirements for this position?
  • University degree in biotechnology, biochemistry, biology or similar field
  • Optional Ph.D. in these fields
  • At least 3 years of experience in research and industrial bioprocessing as well as people leadership
  • Knowledge in protein purification, industrial bioprocessing (USP/DSP), protein analytics, IT workflows in a R&D environment
  • Project and lab management
  • Fluent English language skills
  • Solid knowledge in data management
In principal, this position is also suitable for part time work.
This position is limited to two years.
Remuneration bandwidth:    AT 1/2
Department:                         PRLPB
Application period until at least 23.03.2020.
(Application possible as long as the position is posted)
We look forward to receiving your application!
Your application:
For your application, please keep it simple. We only ask you for an updated CV. A motivation letter is also not needed. However, please let us get to know you by submitting a short essay (max. half a page) exposing the meaning the following topic has to you:
 “Leading in an R&D matrix: please explain the challenges and opportunities for organizations like Roche”
Ideally, please submit CV + essay in one document. All further relevant documents such as certificates, reference letters etc. will be handled at a later stage.
Whom to contact
E. Hallermayer-Jahreiß +498856/60 19253
For technical questions, you can use our FAQ
Should you have recruiting specific questions on your application or the specific job posting, please contact the responsible recruiter (E. Hallermayer-Jahreiß, +498856/60 19253).
Refer a Friend
This position is relevant to the Refer a Friend Program for all employees of Roche Germany. In case of a successful referral a reward in accordance to the valid regulations and conditions will be paid out.

Comments

Post a Comment

Popular posts from this blog

European Union will close its borders to all non-essential travel to fight coronavirus

Madrid (ITNTV) The European Union will close its borders to all non-essential travel as it attempts to contain the  ongoing spread of the coronavirus  on the continent. "The less travel, the more we can contain the virus," European Commission President Ursula von der Leyen said Monday following a video conference between G7 leaders. She appeared confident that the European Council would sign off on the restriction in a Tuesday vote. The bloc's member states imposed aggressive measures on Monday,  days after the  World Health Organization (WHO) said Europe was at the epicenter of the pandemic. French President Emmanuel Macron declared "war" on the virus during a national address on Monday, banning all social events across the country -- including family gatherings. Macron said those who have gathered in public places in recent days have not been respecting previous measures to limit the outbreak's spread in France, which as of Monday had 5,380 con...
Post a Comment
Read more

PhD positions: In Institute of Biochemistry, Jena University Hospital - Friedrich Schiller University Jena, Germany

PhD positions: In Institute of Biochemistry, Jena University Hospital - Friedrich Schiller University Jena, Germany   🇩🇪 . Subjects: Neurobiology / Imaging Description: 1 PhD position in Neurobiology / Imaging Prof. Britta Qualmann, Inst. of Biochem. I, UKJ - Friedrich Schiller University Jena, Germany Prof. Christian Geis, Section of Translat. Neuroimmunol., Dept. Neurol., UKJ We seek for a productive addition to our research team in a collaborative project. We plan to study pathomechanisms of synaptic changes underlying autoimmune disorders of the central nervous system applying super-resolution microscopy. The Geis lab examines immune-mediated changes of synapses by interactions with pathogenic human antibodies against neuronal proteins. Short- and long-term effects on neuronal networks are analyzed using electrophysiological and various microscopy methods. The Qualmann lab is an internationally well-known lab that focusses on proteins with the power to s...
Post a Comment
Read more

80 pct of life stopped in Turkey due to outbreak, says interior minister

Turkish citizens, especially those living in metropolises, have been abiding by the “social isolation” principles laid out by the government, Interior Minister  Süleyman Soylu  has said, adding that almost 80 percent of life “stopped” in  Turkey . “Up until now, just our ministry issued 38 circulars, 17 of which concern the borders. Many high-level precautions have been taken. Right now, 80 percent of life stopped in Turkey,” Soylu said on March 26 in an interview with a private broadcaster. Soylu also provided updated figures for passenger traffic. He said that there is a 73 percent decline in inter-city bus services, adding that these services can also be suspended if needed. On intra-city traffic, Soylu said that there has been an 80 percent decline. This figure was 65 percent according to another interview the minister held on March 25. The government has four cruxes it predicates on when taking measures against the spread of the novel  coronaviru...
Post a Comment
Read more